Genmab — April 2016
-
God morgen.

-
Det er jo et event dreven studie så det er svært at sige. Jo længere tid der går kan jo være tegn på at patienter lever længe dvs. positivt. Så længe det bare ikke er kontrolarmen der performer

-
Jeg har bare ikke fantasi til at forestille mig dårlie resultater når selv Elotuzumab kunne vise PFS forbedring uden større problemer
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind